Drug-Coated Balloon Venoplasty for In-Stent Restenosis in a Patient with Recurrent Pulmonary Vein Stenosis Post Ablation for Atrial Fibrillation: Initial Experience with a New Treatment Technique

Jonathan Rosenberg, Westby G. Fisher, Mayra Guerrero, Steve Smart, Justin Levisay, Ted Feldman, Michael Salinger

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pulmonary vein stenosis (PVS) is an uncommon but serious complication following radiofrequency ablation for atrial fibrillation. Occurrence of this complication has risen with increased rates of ablation procedures, with >50,000 AF ablation procedures performed per year, and can occur within weeks to months post procedure. Currently, the main therapies for PVS include percutaneous interventions with balloon angioplasty and stenting, but these treatments are complicated by a high rate of restenosis. The optimal treatment for recurrent pulmonary vein in-stent restenosis has not been determined. We describe the novel use of a paclitaxel drug-coated balloon for the treatment of in-stent restenosis of the pulmonary veins.

Original languageEnglish (US)
Pages (from-to)E44-E48
JournalJournal of Invasive Cardiology
Volume28
Issue number5
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Atrial Fibrillation
Stents
Pulmonary Veins
Pharmaceutical Preparations
Balloon Angioplasty
Therapeutics
Paclitaxel
Pulmonary Vein Stenosis

Keywords

  • pulmonary vein stenosis
  • radiofrequency ablation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Drug-Coated Balloon Venoplasty for In-Stent Restenosis in a Patient with Recurrent Pulmonary Vein Stenosis Post Ablation for Atrial Fibrillation : Initial Experience with a New Treatment Technique. / Rosenberg, Jonathan; Fisher, Westby G.; Guerrero, Mayra; Smart, Steve; Levisay, Justin; Feldman, Ted; Salinger, Michael.

In: Journal of Invasive Cardiology, Vol. 28, No. 5, 01.05.2016, p. E44-E48.

Research output: Contribution to journalArticle

@article{aab31a7862b14a93a8b14275b2889f24,
title = "Drug-Coated Balloon Venoplasty for In-Stent Restenosis in a Patient with Recurrent Pulmonary Vein Stenosis Post Ablation for Atrial Fibrillation: Initial Experience with a New Treatment Technique",
abstract = "Pulmonary vein stenosis (PVS) is an uncommon but serious complication following radiofrequency ablation for atrial fibrillation. Occurrence of this complication has risen with increased rates of ablation procedures, with >50,000 AF ablation procedures performed per year, and can occur within weeks to months post procedure. Currently, the main therapies for PVS include percutaneous interventions with balloon angioplasty and stenting, but these treatments are complicated by a high rate of restenosis. The optimal treatment for recurrent pulmonary vein in-stent restenosis has not been determined. We describe the novel use of a paclitaxel drug-coated balloon for the treatment of in-stent restenosis of the pulmonary veins.",
keywords = "pulmonary vein stenosis, radiofrequency ablation",
author = "Jonathan Rosenberg and Fisher, {Westby G.} and Mayra Guerrero and Steve Smart and Justin Levisay and Ted Feldman and Michael Salinger",
year = "2016",
month = "5",
day = "1",
language = "English (US)",
volume = "28",
pages = "E44--E48",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "5",

}

TY - JOUR

T1 - Drug-Coated Balloon Venoplasty for In-Stent Restenosis in a Patient with Recurrent Pulmonary Vein Stenosis Post Ablation for Atrial Fibrillation

T2 - Initial Experience with a New Treatment Technique

AU - Rosenberg, Jonathan

AU - Fisher, Westby G.

AU - Guerrero, Mayra

AU - Smart, Steve

AU - Levisay, Justin

AU - Feldman, Ted

AU - Salinger, Michael

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Pulmonary vein stenosis (PVS) is an uncommon but serious complication following radiofrequency ablation for atrial fibrillation. Occurrence of this complication has risen with increased rates of ablation procedures, with >50,000 AF ablation procedures performed per year, and can occur within weeks to months post procedure. Currently, the main therapies for PVS include percutaneous interventions with balloon angioplasty and stenting, but these treatments are complicated by a high rate of restenosis. The optimal treatment for recurrent pulmonary vein in-stent restenosis has not been determined. We describe the novel use of a paclitaxel drug-coated balloon for the treatment of in-stent restenosis of the pulmonary veins.

AB - Pulmonary vein stenosis (PVS) is an uncommon but serious complication following radiofrequency ablation for atrial fibrillation. Occurrence of this complication has risen with increased rates of ablation procedures, with >50,000 AF ablation procedures performed per year, and can occur within weeks to months post procedure. Currently, the main therapies for PVS include percutaneous interventions with balloon angioplasty and stenting, but these treatments are complicated by a high rate of restenosis. The optimal treatment for recurrent pulmonary vein in-stent restenosis has not been determined. We describe the novel use of a paclitaxel drug-coated balloon for the treatment of in-stent restenosis of the pulmonary veins.

KW - pulmonary vein stenosis

KW - radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=84969524454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969524454&partnerID=8YFLogxK

M3 - Article

C2 - 27145055

AN - SCOPUS:84969524454

VL - 28

SP - E44-E48

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 5

ER -